Immunological reconstitution after bone marrow transplantation

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 2, 1996, Pages 148-150

  Porta, F ^a   Mazzolari, E ^a   Lanfranchi, A ^b   Pennacchio, M ^a   Fischer, A ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b III Laboratorio Analisi   (Italy)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN;

BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CLINICAL PROTOCOL; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; GENE THERAPY; HLA MATCHING; HUMAN; HUMORAL IMMUNITY; INTRAVENOUS DRUG ADMINISTRATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SURVIVAL;

BONE MARROW TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNITY;

EID: 0029827501     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Fischer A, Landais P, Freidrich W, Porta F et al: European experience of bone marrow transplantation in SCED. Lancet 1990; 336: 850-854.
2. Fischer A, Landais P, Friedrich W, Porta F et al: Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for immunodeficiency. Blood 1994; 83: 1149-1155.
3. Lum G. The kinetics of immune reconstitution after human marrow transplantation., 1987; 69: 369-80.
4. Lum G: Immune recovery after bone marrow transplntation. Bone Marrow Transplantation 1990; 3: 659-74,
5. Wijnaendts, Le deist F, Grieselli C, Fischer A: Development of immunological functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 1989; 74: 2212
6. Keever CA, Small TN, Flomberg N.Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood, 1989; 73: 1340-50.
7. Dror Y, Gallagher R, Wara DW, Colombe BW et al: Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 1993; 81: 2021
8. Hershfield M.S., Buckley R.H., Greenberg M.L. et al: Treatment of adenosine deaminase defciency with polyethylene lycol-modified adenosine deaminase. N. Engl. J. Med., 1987; 316: 589-596,
9. Bordignon C, Notarangelo LD, Nobili N et al: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science, 1995; 270: 470-5.
10. Filipovich AH, Porta F et al: Unrelated (URD) bone marrow transplantation (BMT) for primary immunodeficiencies: an international review. Blood 1994, Suppl. 1, 394,
11. Porta F, Mazzolari E: MUD BMT in primary immunodeficiencies and osteopetrosis. Bone Marrow Transplantation 1996; 17, Suppl.1, 53,
12. Friedrich W, Muller S, Schreiner T: Purified CD34+ stem cells from HLA-haploidentical parental donors for transplantation in SCID. Blood cells and bone marrow transplants, Keystone symposia, Colorado, January 15-21 1996, 43.